PerformanceMedium Risk

IGF-2

Also known as: Insulin-like Growth Factor 2, IGF-II

Half-life:: ~10-20 minutes

Administration Routes

subcutaneous injectionintramuscular injection

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Binds IGF-1R and insulin receptor variant A; promotes anabolic signaling in muscle and fat; activates PI3K/Akt/mTOR pathway; different receptor binding profile than IGF-1

The second insulin-like growth factor, with anabolic effects on muscle and metabolism. Has a different receptor binding profile than IGF-1, potentially with a more favorable safety margin.

Primary Research Areas

muscle growth
fat metabolism
tissue development
recovery

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Endogenous growth factor. No FDA-approved exogenous IGF-2 drug product. No NDA or IND for IGF-2 as primary active ingredient. Research use only.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find IGF-2

No active associated providers listed yet.